These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6146808)

  • 41. Immunoelectrophoretic determination of albumin and IgG in serum and cerebrospinal fluid in dogs with neurological diseases.
    Bichsel P; Vandevelde M; Vandevelde E; Affolter U; Pfister H
    Res Vet Sci; 1984 Jul; 37(1):101-7. PubMed ID: 6473908
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Measurement of cerebrospinal fluid IgG in the diagnosis of multiple sclerosis.
    Willoughby EW
    Proc Aust Assoc Neurol; 1976; 13():127-33. PubMed ID: 829365
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relation between benign course of multiple sclerosis and low-grade humoral immune response in cerebrospinal fluid.
    Stendahl-Brodin L; Link H
    J Neurol Neurosurg Psychiatry; 1980 Feb; 43(2):102-5. PubMed ID: 7359146
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Practical value of IgG index and IgG synthesis rate in multiple sclerosis].
    Liu M; Xu W
    Hua Xi Yi Ke Da Xue Xue Bao; 1994 Jun; 25(2):215-7. PubMed ID: 7806204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The complex relationship between oligoclonal bands, lymphocytes in the cerebrospinal fluid, and immunoglobulin G antibodies in multiple sclerosis: Indication of serum contribution.
    Beseler C; Vollmer T; Graner M; Yu X
    PLoS One; 2017; 12(10):e0186842. PubMed ID: 29059249
    [TBL] [Abstract][Full Text] [Related]  

  • 46. VIP in cerebrospinal fluid of patients with multiple sclerosis.
    Andersen O; Fahrenkrug J; Wikkelsø C; Johansson BB
    Peptides; 1984; 5(2):435-7. PubMed ID: 6473167
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Simultaneous assay of IgG and albumin in the cerebrospinal fluid].
    Besset A; Deslandes A; Mouray H
    Ann Biol Clin (Paris); 1974; 32(6):507-13. PubMed ID: 4219829
    [No Abstract]   [Full Text] [Related]  

  • 48. CSF immunoglobulins G in multiple sclerosis.
    Caputo D; Zaffaroni M; Procaccia S
    Boll Ist Sieroter Milan; 1982; 61(5):393-403. PubMed ID: 6927183
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values.
    Tibbling G; Link H; Ohman S
    Scand J Clin Lab Invest; 1977 Sep; 37(5):385-90. PubMed ID: 337459
    [No Abstract]   [Full Text] [Related]  

  • 50. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
    Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
    PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elevated soluble interleukin-2 receptor levels in patients with active multiple sclerosis.
    Adachi K; Kumamoto T; Araki S
    Ann Neurol; 1990 Nov; 28(5):687-91. PubMed ID: 2260855
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of ACTH therapy on IgG synthesis in cerebrospinal fluid spaces in patients with disseminated sclerosis].
    Wender M; Michałowska G; Wajgt A
    Neurol Neurochir Pol; 1986; 20(5):437-43. PubMed ID: 3035406
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 2. Laboratory results.
    Compston DA; Milligan NM; Hughes PJ; Gibbs J; McBroom V; Morgan BP; Campbell AK
    J Neurol Neurosurg Psychiatry; 1987 May; 50(5):517-22. PubMed ID: 2953865
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis.
    Jongen PJ; Lamers KJ; Doesburg WH; Lemmens WA; Hommes OR
    J Neurol Neurosurg Psychiatry; 1997 Oct; 63(4):446-51. PubMed ID: 9343121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Haptoglobin levels in the serum and the cerebrospinal fluid patients with multiple sclerosis].
    Rosnowska M; Cendrowski W
    Neurol Neurochir Pol; 1978; 12(5):579-85. PubMed ID: 724031
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study.
    Brickshawana A; Hinson SR; Romero MF; Lucchinetti CF; Guo Y; Buttmann M; McKeon A; Pittock SJ; Chang MH; Chen AP; Kryzer TJ; Fryer JP; Jenkins SM; Cabre P; Lennon VA
    Lancet Neurol; 2014 Aug; 13(8):795-806. PubMed ID: 25008548
    [TBL] [Abstract][Full Text] [Related]  

  • 57. T cells from multiple sclerosis patients recognize immunoglobulin G from cerebrospinal fluid.
    Holmøy T; Vandvik B; Vartdal F
    Mult Scler; 2003 Jun; 9(3):228-34. PubMed ID: 12814167
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use and abuse of the cerebrospinal fluid IgG profile in the adult: a practical evaluation.
    Hershey LA; Trotter JL
    Ann Neurol; 1980 Oct; 8(4):426-34. PubMed ID: 6776879
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Study on the concentrations of cerebrospinal fluid immunoglobulin G and albumin in children.
    Hung KL; Chang MT; Tsai ML; Chen WC
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1992; 33(5):325-31. PubMed ID: 1296442
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cerebrospinal fluid proteins in multiple sclerosis.
    Lamoureux G; Jolicoeur R; Giard N; St-Hilaire M; Duplantis F
    Neurology; 1975 Jun; 25(6):537-46. PubMed ID: 48211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.